問卷

TPIDB > Search Result

Search Result

篩選

List

1858Cases

2022-11-01 - 2025-04-14

Phase III

Completed
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
  • Condition/Disease

    Lung Diseases, Interstitial

  • Test Drug

    BI 1015550

Participate Sites
9Sites

Not yet recruiting8Sites

Recruiting1Sites

2008-08-01 - 2010-11-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2011-12-01 - 2013-06-30

Phase IV

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2010-09-01 - 2015-09-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2020-07-24 - 2020-11-06

Phase II

Completed
An open label, randomized Phase II study of BI 754091 alone or in combination with BI 836880 in patients with chemotherapy resistant, unresectable, metastatic squamous cell carcinoma of the anal canal
  • Condition/Disease

    anal canal

  • Test Drug

    BI 754091; BI 836880

Participate Sites
4Sites

Terminated4Sites

2008-01-01 - 2009-04-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2008-01-01 - 2009-03-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2005-01-01 - 2006-08-01

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2025-06-30 - 2032-05-01

Phase II

Not yet recruiting
A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants with Advanced Prostate Cancer
  • Condition/Disease

    Advanced Prostate Cancer

  • Test Drug

    ASP5541

Participate Sites
6Sites

Recruiting6Sites

2024-12-02 - 2027-12-31

Phase I/II

Active
xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    xxxxxx

Participate Sites
4Sites

Recruiting4Sites